Cargando…
A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis
INTRODUCTION: The severity of joint damage progression in rheumatoid arthritis (RA) is heritable. Several genetic variants have been identified, but together explain only part of the total genetic effect. Variants in Interleukin-6 (IL-6), Interleukin-10 (IL-10), C5-TRAF1, and Fc-receptor-like-3 (FCR...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318544/ https://www.ncbi.nlm.nih.gov/pubmed/25566937 http://dx.doi.org/10.1186/s13075-014-0514-0 |
_version_ | 1782355862885498880 |
---|---|
author | van Steenbergen, Hanna W Rodríguez-Rodríguez, Luis Berglin, Ewa Zhernakova, Alexandra Knevel, Rachel Ivorra-Cortés, Jose Huizinga, Tom WJ Fernández-Gutiérrez, Benjamin Gregersen, Peter K Rantapää-Dahlqvist, Solbritt van der Helm-van Mil, Annette HM |
author_facet | van Steenbergen, Hanna W Rodríguez-Rodríguez, Luis Berglin, Ewa Zhernakova, Alexandra Knevel, Rachel Ivorra-Cortés, Jose Huizinga, Tom WJ Fernández-Gutiérrez, Benjamin Gregersen, Peter K Rantapää-Dahlqvist, Solbritt van der Helm-van Mil, Annette HM |
author_sort | van Steenbergen, Hanna W |
collection | PubMed |
description | INTRODUCTION: The severity of joint damage progression in rheumatoid arthritis (RA) is heritable. Several genetic variants have been identified, but together explain only part of the total genetic effect. Variants in Interleukin-6 (IL-6), Interleukin-10 (IL-10), C5-TRAF1, and Fc-receptor-like-3 (FCRL3) have been described to associate with radiographic progression, but results of different studies were incongruent. We aimed to clarify associations of these variants with radiographic progression by evaluating six independent cohorts. METHODS: In total 5,895 sets of radiographs of 2,493 RA-patients included in six different independent datasets from the Netherlands, Sweden, Spain and North-America were studied in relation to rs1800795 (IL-6), rs1800896 (IL-10), rs2900180 (C5-TRAF1) and rs7528684 (FCRL3). Associations were tested in the total RA-populations and in anti-citrullinated peptide antibodies (ACPA)-positive and ACPA-negative subgroups per cohort, followed by meta-analyses. Furthermore, the associated region C5-TRAF1 was fine-mapped in the ACPA-negative Dutch RA-patients. RESULTS: No associations were found for rs1800795 (IL-6), rs1800896 (IL-10) and rs7528684 (FCRL3) in the total RA-population and after stratification for ACPA. Rs2900180 in C5-TRAF1 was associated with radiographic progression in the ACPA-negative population (P-value meta-analysis = 5.85 × 10(−7)); the minor allele was associated with more radiographic progression. Fine-mapping revealed a region of 66Kb that was associated; the lowest P-value was for rs7021880 in TRAF1. The P-value for rs7021880 in meta-analysis was 6.35 × 10(−8). Previous studies indicate that the region of rs7021880 was associated with RNA expression of TRAF1 and C5. CONCLUSION: Variants in IL-6, IL-10 and FCRL3 were not associated with radiographic progression. Rs2900180 in C5-TRAF1 and linked variants in a 66Kb region were associated with radiographic progression in ACPA-negative RA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-014-0514-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4318544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43185442015-02-06 A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis van Steenbergen, Hanna W Rodríguez-Rodríguez, Luis Berglin, Ewa Zhernakova, Alexandra Knevel, Rachel Ivorra-Cortés, Jose Huizinga, Tom WJ Fernández-Gutiérrez, Benjamin Gregersen, Peter K Rantapää-Dahlqvist, Solbritt van der Helm-van Mil, Annette HM Arthritis Res Ther Research Article INTRODUCTION: The severity of joint damage progression in rheumatoid arthritis (RA) is heritable. Several genetic variants have been identified, but together explain only part of the total genetic effect. Variants in Interleukin-6 (IL-6), Interleukin-10 (IL-10), C5-TRAF1, and Fc-receptor-like-3 (FCRL3) have been described to associate with radiographic progression, but results of different studies were incongruent. We aimed to clarify associations of these variants with radiographic progression by evaluating six independent cohorts. METHODS: In total 5,895 sets of radiographs of 2,493 RA-patients included in six different independent datasets from the Netherlands, Sweden, Spain and North-America were studied in relation to rs1800795 (IL-6), rs1800896 (IL-10), rs2900180 (C5-TRAF1) and rs7528684 (FCRL3). Associations were tested in the total RA-populations and in anti-citrullinated peptide antibodies (ACPA)-positive and ACPA-negative subgroups per cohort, followed by meta-analyses. Furthermore, the associated region C5-TRAF1 was fine-mapped in the ACPA-negative Dutch RA-patients. RESULTS: No associations were found for rs1800795 (IL-6), rs1800896 (IL-10) and rs7528684 (FCRL3) in the total RA-population and after stratification for ACPA. Rs2900180 in C5-TRAF1 was associated with radiographic progression in the ACPA-negative population (P-value meta-analysis = 5.85 × 10(−7)); the minor allele was associated with more radiographic progression. Fine-mapping revealed a region of 66Kb that was associated; the lowest P-value was for rs7021880 in TRAF1. The P-value for rs7021880 in meta-analysis was 6.35 × 10(−8). Previous studies indicate that the region of rs7021880 was associated with RNA expression of TRAF1 and C5. CONCLUSION: Variants in IL-6, IL-10 and FCRL3 were not associated with radiographic progression. Rs2900180 in C5-TRAF1 and linked variants in a 66Kb region were associated with radiographic progression in ACPA-negative RA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-014-0514-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-01-08 2015 /pmc/articles/PMC4318544/ /pubmed/25566937 http://dx.doi.org/10.1186/s13075-014-0514-0 Text en © van Steenbergen et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article van Steenbergen, Hanna W Rodríguez-Rodríguez, Luis Berglin, Ewa Zhernakova, Alexandra Knevel, Rachel Ivorra-Cortés, Jose Huizinga, Tom WJ Fernández-Gutiérrez, Benjamin Gregersen, Peter K Rantapää-Dahlqvist, Solbritt van der Helm-van Mil, Annette HM A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis |
title | A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis |
title_full | A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis |
title_fullStr | A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis |
title_full_unstemmed | A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis |
title_short | A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis |
title_sort | genetic study on c5-traf1 and progression of joint damage in rheumatoid arthritis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318544/ https://www.ncbi.nlm.nih.gov/pubmed/25566937 http://dx.doi.org/10.1186/s13075-014-0514-0 |
work_keys_str_mv | AT vansteenbergenhannaw ageneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT rodriguezrodriguezluis ageneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT berglinewa ageneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT zhernakovaalexandra ageneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT knevelrachel ageneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT ivorracortesjose ageneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT huizingatomwj ageneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT fernandezgutierrezbenjamin ageneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT gregersenpeterk ageneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT rantapaadahlqvistsolbritt ageneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT vanderhelmvanmilannettehm ageneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT vansteenbergenhannaw geneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT rodriguezrodriguezluis geneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT berglinewa geneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT zhernakovaalexandra geneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT knevelrachel geneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT ivorracortesjose geneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT huizingatomwj geneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT fernandezgutierrezbenjamin geneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT gregersenpeterk geneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT rantapaadahlqvistsolbritt geneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis AT vanderhelmvanmilannettehm geneticstudyonc5traf1andprogressionofjointdamageinrheumatoidarthritis |